| Ident. | Authors (with country if any) | Title |
|---|
| 000071 |
Jonathan R. Evans [Royaume-Uni] ; Sarah L. Mason [Royaume-Uni] ; Caroline H. Williams-Gray [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] ; Carol Brayne [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | The natural history of treated Parkinson's disease in an incident, community based cohort |
| 000184 |
Wassilios G. Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José A. Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David M. Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
| 000353 |
Carmen Agustín-Pav N [Royaume-Uni] ; John Parkinson [Royaume-Uni] ; Mei-See Man [Royaume-Uni] ; Angela C. Roberts [Royaume-Uni] | Contribution of the amygdala, but not orbitofrontal or medial prefrontal cortices, to the expression of flavour preferences in marmoset monkeys |
| 000419 |
A. E. Vanhaesebrouck [Royaume-Uni] ; G. D. Shelton [États-Unis] ; L. Garosi [Royaume-Uni] ; T. R. Harcourt-Brown [Royaume-Uni] ; J. Couturier [Royaume-Uni] ; S. Behr [Royaume-Uni] ; R. J. Harvey [Royaume-Uni] ; N. D. Jeffery [Royaume-Uni, États-Unis] ; K. Matiasek [Allemagne] ; W. F. Blakemore [Royaume-Uni] ; N. Granger [Royaume-Uni] | A Novel Movement Disorder in Related Male Labrador Retrievers Characterized by Extreme Generalized Muscular Stiffness |
| 000436 |
Pablo Garcia-Reitbck [Royaume-Uni] ; Oleg Anichtchik [Royaume-Uni] ; Arianna Bellucci [Italie] ; Mariangela Iovino [Royaume-Uni] ; Chiara Ballini [Italie] ; Elena Fineberg [Royaume-Uni] ; Bernardino Ghetti [États-Unis] ; Laura Della Corte [Italie] ; Pierfranco Spano [Italie] ; George K. Tofaris [Royaume-Uni] ; Michel Goedert [Royaume-Uni] ; Maria Grazia Spillantini [Royaume-Uni] | SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinsons disease |
| 000600 |
Laura E. Hughes [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Adrian M. Owen [Royaume-Uni] ; James B. Rowe [Royaume-Uni] | Parkinson's disease and healthy aging: Independent and interacting effects on action selection |
| 000853 |
Caroline H. Williams-Gray [Royaume-Uni] ; Jonathan R. Evans [Royaume-Uni] ; An Goris [Royaume-Uni, Belgique] ; Thomas Foltynie [Royaume-Uni] ; Maria Ban [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; Carol Brayne [Royaume-Uni] ; Bhaskar S. Kolachana [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Stephen J. Sawcer [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort |
| 000B56 |
Gráinne C. O Eeffe [Royaume-Uni] ; Andrew W. Michell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Biomarkers in Huntington's and Parkinson's Disease |
| 000C95 |
L. Ishihara-Paul [Royaume-Uni] ; N. W. J. Wainwright [Royaume-Uni] ; K. Khaw [Royaume-Uni] ; R. N. Luben [Royaume-Uni] ; A. A. Welch [Royaume-Uni] ; N. E. Day [Royaume-Uni] ; C. Brayne [Royaume-Uni] ; P. G. Surtees [Royaume-Uni] | Prospective association between emotional health and clinical evidence of Parkinson’s disease |
| 000D05 |
David Stuckler [Royaume-Uni] | Population Causes and Consequences of Leading Chronic Diseases: A Comparative Analysis of Prevailing Explanations |
| 000F44 |
An Goris [Royaume-Uni, Belgique] ; Caroline H. Williams-Gray [Royaume-Uni] ; Graeme R. Clark [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] ; Simon J. G. Lewis [Royaume-Uni] ; Joanne Brown [Royaume-Uni] ; Maria Ban [Royaume-Uni] ; Maria G. Spillantini [Royaume-Uni] ; Alastair Compston [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Stephen J. Sawcer [Royaume-Uni] | Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease |
| 000F59 |
Lianna Ishihara [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Liling Warren [États-Unis] ; Rim Amouri [Tunisie] ; Kelly Lyons [États-Unis] ; Catherine Wielinski [États-Unis] ; Christine Hunter [États-Unis] ; Jina E. Swartz [Royaume-Uni] ; Ramu Elango [Royaume-Uni] ; P. Anthony Akkari [États-Unis] ; David Leppert [Royaume-Uni] ; Linda Surh [Royaume-Uni] ; Kevin H. Reeves [États-Unis] ; Siwan Thomas [Royaume-Uni] ; Leigh Ragone [États-Unis] ; Nobutaka Hattori [Japon] ; Rajesh Pahwa [États-Unis] ; Joseph Jankovic [États-Unis] ; Martha Nance [États-Unis] ; Alan Freeman [États-Unis] ; Neziha Gouider-Khouja [Tunisie] ; Mounir Kefi [Tunisie] ; Mourad Zouari [Tunisie] ; Samia Ben Sassi [Tunisie] ; Samia Ben Yahmed [Tunisie] ; Ghada El Euch-Fayeche [Tunisie] ; Lefkos Middleton [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Ray L. Watts [États-Unis] ; Faycal Hentati [Tunisie] | Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families |
| 000F84 |
Andrew J. Lawrence [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Francesca Spagnolo [Italie] ; Luke Clark [Royaume-Uni] ; Michael R. F. Aitken [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] | Predictors of punding in Parkinson's disease: Results from a questionnaire survey |
| 001057 |
Lianna S. Ishihara [Royaume-Uni] ; Anne Cheesbrough [Royaume-Uni] ; Carol Brayne [Royaume-Uni] ; Anette Schrag [Royaume-Uni] | Estimated life expectancy of Parkinson’s patients compared with the UK population |
| 001161 |
Lianna Ishihara [Royaume-Uni] ; Carol Brayne [Royaume-Uni] | What is the evidence for a premorbid parkinsonian personality: A systematic review |
| 001220 |
Stephen B. Dunnett [Royaume-Uni] ; Anders Bjrklund [Suède] | Prospects for new restorative and neuroprotective treatments in Parkinson's disease |
| 001313 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 001366 |
L. Ishihara [Royaume-Uni] ; C. Brayne [Royaume-Uni] | A systematic review of depression and mental illness preceding Parkinson's disease |
| 001471 |
Catharine A. Winstanley [Royaume-Uni] ; Christelle Baunez [France] ; David E. H. Theobald [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] | Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control |
| 001540 |
Dag Aarsland [Norvège] ; Julia Zaccai [Royaume-Uni] ; Carol Brayne [Royaume-Uni] | A systematic review of prevalence studies of dementia in Parkinson's disease |
| 001602 |
Elanor C. Hinton [Royaume-Uni] ; John A. Parkinson [Royaume-Uni] ; Anthony J. Holland [Royaume-Uni] ; F. Sergio Arana [Royaume-Uni] ; Angela C. Roberts [Royaume-Uni] ; Adrian M. Owen [Royaume-Uni] | Neural contributions to the motivational control of appetite in humans |
| 001621 |
C. Panter-Brick [Royaume-Uni] ; P. G. Lunn [Royaume-Uni] ; R. Goto [Royaume-Uni] ; C. M. Wright [Royaume-Uni] | Immunostimulation and growth faltering in UK infants |
| 001637 |
Catherine Lozza [France] ; Jean-Claude Baron [France, Royaume-Uni] ; David Eidelberg [États-Unis] ; Marc J. Mentis [États-Unis] ; Maren Carbon [États-Unis] ; Rose-Marie Marié [France] | Executive processes in Parkinson's disease: FDG‐PET and network analysis |
| 001821 |
T. Foltynie [Royaume-Uni] ; S. Sawcer [Royaume-Uni] ; C. Brayne [Royaume-Uni] ; R A Barker [Royaume-Uni] | The genetic basis of Parkinson's disease |
| 001951 |
Barry J. Everitt [Royaume-Uni] ; Anthony Dickinson [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] | The neuropsychological basis of addictive behaviour |
| 001B60 |
Maria Grazia Spillantini [Royaume-Uni] ; Michel Goedert [Royaume-Uni] | The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy |
| 001E58 |
J. M Henderson [Royaume-Uni] ; S. B Dunnett [Royaume-Uni] | Targeting the subthalamic nucleus in the treatment of Parkinson’s disease |
| 002064 |
Timothy M. Cox [Royaume-Uni] ; J. Paul Schofield [Royaume-Uni] | 3 Gaucher's disease: clinical features and natural history |
| 002176 |
Christian Spenger [Suisse] ; K. Haque [Royaume-Uni] ; Lorenz Studer [Suisse] ; Ljudmila Evtouchenko [Suisse] ; Bendicht Wagner [Suisse] ; Beatrice Bühler [Suisse] ; Urban Lendahl [Suède] ; B. Dunnett [Royaume-Uni] ; W. Seiler [Suisse] | Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons |
| 002849 |
O. Isacson [Royaume-Uni] ; D. Riche [France] ; P. Hantraye [France] ; V. Sofroniew [Royaume-Uni] ; M. Maziere [France] | A primate model of Huntington's disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen |
| 002B41 |
C. J. Fowler [Irlande (pays)] ; L. Oreland [Suède] ; B. A. Callingham [Royaume-Uni] | The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J‐508: their properties and applications |
| 002B68 |
David Parkinson [Royaume-Uni] ; Geoffrey A. Lyles [Royaume-Uni] ; Barbara J. Browne [Royaume-Uni] ; Brian A. Callingham [Royaume-Uni] | Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver |
